Download PDF
Dtsch Med Wochenschr 2014; 139(09): 430-433
DOI: 10.1055/s-0034-1369815
Übersicht | Review article
Diabetologie
© Georg Thieme Verlag KG Stuttgart · New York

Dosierungsunregelmäßigkeiten und Hypoglykämien in der Insulintherapie des Typ-2-Diabetes

Die GAPP2™ StudieDosing irregularities and hypoglycaemia in insulin treatment of type 2 diabetes: the GAPP2TM study
M. Grundner
1   Diabetologische Schwerpunktpraxis, Frankfurt am Main
› Author Affiliations
Further Information

Publication History

18 July 2013

09 December 2013

Publication Date:
20 February 2014 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Diabetes Typ 2 - Hypoglykämie - Insulin

Keywords

diabetes type 2 - hypoglycaemia - insulin
 

  • Literatur

  • 1 Atsumi Y, Brod M, Barnett AH et al. GAPP2™: Global survey finds that a quarter of Japanese type 2 diabetes downplays insulin non-adherence to their healthcare professionals. Diabetologia 2012; 55 (Suppl. 01) 397
    PubMedSearch in Google Scholar
  • 2 Brod M, Rana A, Barnett AH. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Current Medical Research & Opinion 2012; 28: 1947-1958
    CrossrefPubMedSearch in Google Scholar
  • 3 Brod M, Rana A, Barnett AH. Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimes and reduced doses. Current Medical Research & Opinion 2012; 28: 1933-1946
    CrossrefPubMedSearch in Google Scholar
  • 4 Brod M, Christensen T, Bushnell DM. The impact of non-severe hypoglycemic events on daytime function and diabetes management among adults with type 1 and type 2 diabetes. J Med Econ 2012; 15: 869-77
    CrossrefPubMedSearch in Google Scholar
  • 5 Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26: 1902-1912
    CrossrefPubMedSearch in Google Scholar
  • 6 Davis RE, Morrissey M, Peters JR et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005; 21: 1477-83
    CrossrefPubMedSearch in Google Scholar
  • 7 Grundner M, Steiner U, Brod M. GAPP2™: Dosierungsunregelmäßigkeiten und Hypoglykämien bei insulinbehandelten Patienten mit Typ 2 Diabetes in Deutschland. Diabetologie und Stoffwechsel 2013; (Suppl. 01) Poster 125
    PubMedSearch in Google Scholar
  • 8 Leiter LA, Yale J-F, Chiasson J-L et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes 2005; 29: 186-92
    PubMedSearch in Google Scholar
  • 9 Lundkvist J, Berne C, Bolinder B et al. The economic and quality of life impact of hypoglycemia. Eur J Health Econom 2005; 50: 197-202
    PubMedSearch in Google Scholar
  • 10 Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009; 32: 193-203
    CrossrefPubMedSearch in Google Scholar
  • 11 Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ 2000; 321: 405-412
    CrossrefPubMedSearch in Google Scholar
  • 12 Tahrani A, Barnett AH, Brod M et al. GAPP2™: Global survey finds three quarters of patients experience hypoglycaemia on insulin analogue causing dose irregularities and increased blood-glucose monitoring. Diabetologia 2012; 55 (Suppl. 01) 98-99
    PubMedSearch in Google Scholar
  • 13 Unger J. Uncovering undetected hypoglycemic events. Diab Metab Syndr Obes 2012; 5: 57-74
    PubMedSearch in Google Scholar